
This study, published as a preprint in medRxiv, investigated the outcomes of breast cancer (BC) patients who also had COVID-19. The researchers analyzed data from the COVID-19 and Cancer Consortium registry, focusing on females with BC and laboratory-confirmed SARS-CoV-2 infection between March 2020 and June 2021 in the US. They found that older age, Black patients, Asian Americans and Pacific Islanders, and other racial/ethnic groups had higher odds of experiencing severe COVID-19. Poor ECOG performance status, pre-existing cardiovascular and pulmonary comorbidities, diabetes mellitus, and active/progressing cancer were also associated with worse outcomes. The study highlights disparities among underrepresented racial/ethnic populations and their increased risk of severe COVID-19 outcomes.
Like
Save
Share